Supply problems with an important veterinary sedative have prompted the Government to permit alternative products to be imported.

Supply problems with an important veterinary sedative have prompted the Government to permit alternative products to be imported.

Two acepromazine (ACP) injections made by Novartis Animal Health will not be available in the UK from January 2011.

In response, the VMD has temporarily permitted the import of Calmivet acepromazine solution for injection from French company Vétoquinol.

VMD director of operations John FitzGerald said: “Acepromazine is an important sedative for vets to carry out surgery, so for the health and welfare of animals it was important we allowed an alternative similar product to be imported.”

Novartis has told all recent buyers about the unavailable products, which are ACP Injection 2mg/ml solution for injection Vm 12501/4124 and ACP injection 10mg/ml solution for injection Vm 12501/4125.

In France, Calmivet is licensed for use in dogs, cats and horses not for food-production. UK vets are advised to check doses before administering Calmivet because it is only available as a 5mg/ml injection.

The recommended dose rates (mg per kg bodyweight) in France differ to those licensed for ACP products in the UK. For clinical reasons vets may prefer to use these products in accordance with the UK dose rates for ACP injectable products, adjusting the dose volumes appropriately.

More information is available at the VMD’s website.

 

View your activity >

Leave a Reply

Be the First to Comment!

Notify of
avatar

wpDiscuz